Digital biomarkers measure inflammation in relapsing MS, suggesting early detection may be achievable.
Digital biomarkers show to be capable of measuring changes in individuals when inflammation is detectable on MRI, with the sSDMT additionally capturing changes 6 weeks prior to the MRI, suggesting that early identification of inflammation using these biomarkers may be possible.
No takes yet. Share an insight, caveat, or question.
Molenaar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: